• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

    103.45 -1.38 (-1.31%)
    Streaming Delayed Price Updated: 12:50 PM EST, Feb 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 704,983
    Open 105.90
    Bid (Size) 103.40 (100)
    Ask (Size) 103.49 (100)
    Prev. Close 104.83
    Today's Range 103.37 - 107.45
    52wk Range 29.17 - 124.49
    Shares Outstanding 106,313,250
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Marc Andreessen’s a16z Invests $465 Million in Navan’s Corporate Spending Platform, According to Recent SEC Filing ↗
    a16z Capital Management, the venture firm founded by Marc Andreessen and Ben Horowitz, committed $465 million to Navan, backing its expansion from corporate travel booking into integrated enterprise... 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
    Agios Pharmaceuticals targets rare blood disorders with a marketed anemia drug and a focused clinical-stage pipeline. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +30.9%
    +30.9%
    1 Month
    +5.8%
    +5.8%
    3 Month
    +35.6%
    +35.6%
    6 Month
    +177.5%
    +177.5%
    1 Year
    +150.9%
    +150.9%

    More News

    Read More
    News headline image
    Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Merck In Talks To Acquire Revolution Medicines For About $30B: Report ↗
    Via Stocktwits
    News headline image
    Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
    Via The Motley Fool
    News headline image
    Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗
    Via The Motley Fool
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
    Via MarketMinute
    Topics ETFs Government Initial Public Offering
    News headline image
    Why Revolution Medicines Stock Plummeted by Almost 17% Today ↗
    Via The Motley Fool
    News headline image
    The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
    Via Finterra
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
    Via Finterra
    Topics Economy Initial Public Offering
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Revolution Medicines Stock Sinks After Merck Deal Talks Collapse ↗
    Via Benzinga
    Nasdaq, S&P 500 Futures Open The Week On Edge As Earnings, Tariffs, Fed Decision Loom: Why META, NVDA, RVMD, USAR Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Economy Stocks
    News headline image
    Revolution Medicines Stock Stares At Big Dip After Merck Reportedly Shelves Buyout — But Analyst Flags Opportunity ↗
    Via Stocktwits
    News headline image
    This Fund Put $3.4 Million Into Navan Despite a 60% Post-IPO Drop ↗
    Via The Motley Fool
    Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
    News headline image
    The Great Mid-Cap Rotation: Fed Rate Cuts Spark a New Bull Run for the 'Forgotten' Middle Market
    Via MarketMinute
    Topics Artificial Intelligence Economy Supply Chain
    News headline image
    Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B ↗
    Via Stocktwits
    News headline image
    The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Why Revolution Medicines Stock Surged by 11% Today ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight ↗
    Via Benzinga
    News headline image
    Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Get insights into the top gainers and losers of Thursday's after-hours session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Revolution Medicines, Inc. - Common Stock publicly traded?
    Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
    What exchange does Revolution Medicines, Inc. - Common Stock trade on?
    Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
    The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
    What is the current price of Revolution Medicines, Inc. - Common Stock?
    The current price of Revolution Medicines, Inc. - Common Stock is 103.45
    When was Revolution Medicines, Inc. - Common Stock last traded?
    The last trade of Revolution Medicines, Inc. - Common Stock was at 02/25/26 12:50 PM ET
    What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
    The market capitalization of Revolution Medicines, Inc. - Common Stock is 11.00B
    How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
    Revolution Medicines, Inc. - Common Stock has 11B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.